Luo Ying
SEC CIK 1959160 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GYRE | GYRE THERAPEUTICS, INC. | Dir | 2.57M | — | $82.9K | 2 | 2023-10-30 | 2026-05-05 |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MTI | 2026-05-07 21:58 | 2026-05-05+ | GYRE | GYRE THERAPEUTICS, INC. | Luo Ying | CEO, Dir | S - Sale | $8.04 | -10.3K | 2.57M | -0.4% | -$82.9K |
| DI | 2023-11-22 | 2023-10-30 | GYRE | GYRE THERAPEUTICS, INC. | Luo Ying | Dir | J - Other | — | +2.84M | 2.84M | New | — |
Purchase Sale Sale after option exercise All abbreviations